Chinese guidelines for diagnosis and treatment of melanoma 2018 (English version)

IF 7 2区 医学 Q1 ONCOLOGY Chinese Journal of Cancer Research Pub Date : 2019-08-01 DOI:10.21147/j.issn.1000-9604.2019.04.02
National Health Commission of PRC
{"title":"Chinese guidelines for diagnosis and treatment of melanoma 2018 (English version)","authors":"National Health Commission of PRC","doi":"10.21147/j.issn.1000-9604.2019.04.02","DOIUrl":null,"url":null,"abstract":"1. Overview 2. Screening and diagnosis 2.1 Surveillance and screening of high-risk population 2.2 Diagnosis of melanoma 2.2.1 Clinical symptoms 2.2.2 Imaging diagnosis 2.2.3 Laboratory tests 2.2.4 Focus biopsy 2.3 Pathological diagnosis of melanoma 2.3.1 Criteria for pathological diagnosis 2.3.2 Standard pathological diagnosis of melanoma 2.3.3 Pathological report of melanoma 2.4 Clinical diagnostic criteria and route map of melanoma 3. Staging 4. Treatment 4.1 Surgical treatment 4.1.1 Wide excision 4.1.2 Sentinel lymph node biopsy (SLNB) 4.1.3 Lymph node dissection 4.1.4 Treatment of local recurrence or local metastasis 4.1.5 Postoperative adjuvant therapy (prevention and treatment for metastasis and recurrence) 4.2 Radiotherapy 4.2.1 Adjuvant radiotherapy 4.2.2 Plaque radiotherapy 4.3 Systemic therapy 4.3.1 Systemic therapy and response evaluation criteria 4.3.2 Symptomatic supportive therapy 4.3.3 Therapy of special lesions","PeriodicalId":9882,"journal":{"name":"Chinese Journal of Cancer Research","volume":null,"pages":null},"PeriodicalIF":7.0000,"publicationDate":"2019-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"26","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chinese Journal of Cancer Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21147/j.issn.1000-9604.2019.04.02","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 26

Abstract

1. Overview 2. Screening and diagnosis 2.1 Surveillance and screening of high-risk population 2.2 Diagnosis of melanoma 2.2.1 Clinical symptoms 2.2.2 Imaging diagnosis 2.2.3 Laboratory tests 2.2.4 Focus biopsy 2.3 Pathological diagnosis of melanoma 2.3.1 Criteria for pathological diagnosis 2.3.2 Standard pathological diagnosis of melanoma 2.3.3 Pathological report of melanoma 2.4 Clinical diagnostic criteria and route map of melanoma 3. Staging 4. Treatment 4.1 Surgical treatment 4.1.1 Wide excision 4.1.2 Sentinel lymph node biopsy (SLNB) 4.1.3 Lymph node dissection 4.1.4 Treatment of local recurrence or local metastasis 4.1.5 Postoperative adjuvant therapy (prevention and treatment for metastasis and recurrence) 4.2 Radiotherapy 4.2.1 Adjuvant radiotherapy 4.2.2 Plaque radiotherapy 4.3 Systemic therapy 4.3.1 Systemic therapy and response evaluation criteria 4.3.2 Symptomatic supportive therapy 4.3.3 Therapy of special lesions
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
中国黑色素瘤诊疗指南2018(英文版)
1. 概述2。筛查诊断2.1高危人群监测筛查2.2黑素瘤诊断2.2.1临床症状2.2.2影像学诊断2.2.3实验室检查2.2.4病灶活检2.3黑素瘤病理诊断2.3.1病理诊断标准2.3.2黑素瘤标准病理诊断2.3.3黑素瘤病理报告2.4黑素瘤临床诊断标准及路径图3。举办4。4.1手术治疗4.1.1广泛切除4.1.2前哨淋巴结活检(SLNB) 4.1.3淋巴结清扫4.1.4局部复发或转移治疗4.1.5术后辅助治疗(预防和治疗转移和复发)4.2放疗4.2.1辅助放疗4.2.2斑块放疗4.3全身治疗4.3.1全身治疗及疗效评价标准4.3.2对症支持治疗4.3.3特殊病变的治疗
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
9.80%
发文量
1726
审稿时长
4.5 months
期刊介绍: Chinese Journal of Cancer Research (CJCR; Print ISSN: 1000-9604; Online ISSN:1993-0631) is published by AME Publishing Company in association with Chinese Anti-Cancer Association.It was launched in March 1995 as a quarterly publication and is now published bi-monthly since February 2013. CJCR is published bi-monthly in English, and is an international journal devoted to the life sciences and medical sciences. It publishes peer-reviewed original articles of basic investigations and clinical observations, reviews and brief communications providing a forum for the recent experimental and clinical advances in cancer research. This journal is indexed in Science Citation Index Expanded (SCIE), PubMed/PubMed Central (PMC), Scopus, SciSearch, Chemistry Abstracts (CA), the Excerpta Medica/EMBASE, Chinainfo, CNKI, CSCI, etc.
期刊最新文献
Efficacy and safety of dacomitinib as first-line treatment for advanced non-small cell lung cancer patients with epidermal growth factor receptor 21L858R mutation: A multicenter, case-series study in China. Immune status and combined immunotherapy progression in Kirsten rat sarcoma viral oncogene homolog (KRAS)-mutant tumors. Potential value of detection of minimal residual disease in colorectal cancer following radical resection. Tumor-derived DEFB1 induces immune tolerance by inhibiting maturation of dendritic cell and impairing CD8+ T cell function in esophageal squamous cell carcinoma. SOX11 as a potential prognostic biomarker in hepatocellular carcinoma linked to immune infiltration and ferroptosis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1